Category Archives: Advances in Medication Therapy Compliance

Smart Pills Simplify Medication Compliance Issues

Posted on November 29, 2017 by James J. Murray, Fiction Writer

Experts estimate that patients who do not take their medications as ordered cost this nation approximately $100 billion a year in additional medical expenses. Much of that additional cost is due to patients getting sicker and needing additional treatments or … Continue reading →

Posted in About James J. Murray, About Medications/Pharmacy, Advances in Medication Therapy Compliance, Blog Writers, Blogging, Controlling Drug Costs, Cost of Ignoring Doctor Orders, Cutting Edge Drug Therapy Research, Deaths Related to Therapy Non-Compliance, Developing Technologies, Digital Oral Medication Compliance, Digital Pill Technology, Drug Error Prevention, Drug Errors in The Elderly, Drug Misadventures, Economic Impact of Therapy Non-Compliance, Future Drug Manufacturing Practices, Future of Drug Manufacturing, Innovative Drug Manufacturing Practices, James J. Murray Blog, Making Medications Affordable, Medication Cost Increases, Medication Non-Compliance, Medication Safety Issues, Misuse of Drugs, Murder Mayhem and Medicine, New Blog, New Drug Discoveries, New Drug Manufacturing Methods, New Drug Research, New Research Technology, New Ways to Manufacture Painkillers, Non-Compliance in Medication Therapies, Non-Compliance to Physician Orders, Non-Compliance to Prescription Therapies, Non-Compliance with Medication Therapies, Patient Non-Compliance, Patient Therapy Compliance Issues, Patient Therapy Outcomes, Pharmacy/Pharmaceuticals, Prescription Drug Safety, Prescription Fill Rates, Prescription Fill Statistics in the US, Prescription For Murder Blog, Prescription Prescribing Practices, Prescription Therapy Non-Compliance in the Elderly, Prescription Trends, Reasons for Medication Therapy Non-Compliance, The Pharmacy Profession, The Practice of Pharmacy, Types of Medication Non-Compliance | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | 2 Comments